Imagin Medical Inc
Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It has a license agreement with Lawrence Livermore National Security, LLC to develop, manufacture, and sell a medical imaging device. The company is headquartered in Vancouver, Canada.
Imagin Medical Inc (IMEXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.001x
Based on the latest financial reports, Imagin Medical Inc (IMEXF) has a cash flow conversion efficiency ratio of -0.001x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($17.60K) by net assets ($-11.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Imagin Medical Inc - Cash Flow Conversion Efficiency Trend (2001–2022)
This chart illustrates how Imagin Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Imagin Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imagin Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arete Industries Inc
PINK:ARET
|
0.029x |
|
PhaseRx Inc
PINK:PZRXQ
|
8.545x |
|
ACTIVEX
BE:A4T
|
N/A |
|
Tristar Wellness
PINK:TWSI
|
0.009x |
|
Optigis S.A.
WAR:OPI
|
N/A |
|
Finseta Plc
LSE:FIN
|
0.128x |
|
CUTERA
BE:TJ9
|
0.094x |
|
NAK Stoffe AG
HM:NAK
|
N/A |
Annual Cash Flow Conversion Efficiency for Imagin Medical Inc (2001–2022)
The table below shows the annual cash flow conversion efficiency of Imagin Medical Inc from 2001 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-09-30 | $-13.34 Million | $-2.63 Million | 0.197x | -44.46% |
| 2021-09-30 | $-11.54 Million | $-4.09 Million | 0.355x | -97.15% |
| 2020-09-30 | $-330.74K | $-4.11 Million | 12.433x | +750.43% |
| 2019-09-30 | $2.11 Million | $-4.04 Million | -1.911x | -147.40% |
| 2018-09-30 | $5.99 Million | $-4.63 Million | -0.773x | -159.45% |
| 2017-09-30 | $-511.15K | $-664.32K | 1.300x | +111.63% |
| 2016-09-30 | $125.71K | $-1.40 Million | -11.170x | -866.66% |
| 2015-09-30 | $-175.99K | $-256.42K | 1.457x | +172.40% |
| 2014-09-30 | $226.77K | $-456.38K | -2.013x | -1013.10% |
| 2013-09-30 | $2.23 Million | $-403.86K | -0.181x | -32.52% |
| 2012-09-30 | $2.67 Million | $-364.38K | -0.136x | -12.29% |
| 2011-09-30 | $4.32 Million | $-525.09K | -0.122x | +26.13% |
| 2010-09-30 | $2.88 Million | $-472.89K | -0.164x | +7.50% |
| 2009-09-30 | $2.85 Million | $-507.24K | -0.178x | -757.11% |
| 2008-09-30 | $8.39 Million | $-174.01K | -0.021x | +79.97% |
| 2007-09-30 | $12.77 Million | $-1.32 Million | -0.104x | -23.67% |
| 2006-09-30 | $9.30 Million | $-778.81K | -0.084x | +34.58% |
| 2005-09-30 | $2.34 Million | $-299.29K | -0.128x | +84.20% |
| 2004-09-30 | $245.97K | $-199.28K | -0.810x | -280.87% |
| 2003-09-30 | $380.20K | $-80.88K | -0.213x | +16.20% |
| 2002-09-30 | $901.26K | $-228.77K | -0.254x | -10.19% |
| 2001-09-30 | $807.70K | $-186.07K | -0.230x | -- |